Security key
34962G109
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)
CUSIP: 34962G109
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 6,803,921
- Total 13F value
- $330,057,000
- Share change
- +3,919,513
- SEC-reported price per share
- $48.51
- Number of holders
- 45
- Value change
- +$190,204,632
- Number of buys
- 34
- Number of sells
- 12
- Shares outstanding
- 20,563,488
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
45
Top holders
10
FBRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2020
Previous quarter: Q2 2020
Forte Biosciences, Inc. SEC filings
Forte Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34962G109
Recent filing periods:
Ownership snapshot
Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 4.8%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
4.8%
ORBIMED ADVISORS LLC
4.6%
FRED ALGER MANAGEMENT, LLC
3.5%
VANGUARD GROUP INC
0.3%
BlackRock Finance, Inc.
0.24%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
4.8%
|
$14,272,000
978,857 shares
|
— | 30 Jun 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4.6%
|
$13,856,000
950,316 shares
|
— | 30 Jun 2020 |
| FRED ALGER MANAGEMENT, LLC |
13F
Company
|
3.5%
|
$10,558,000
724,144 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
0.3%
|
$886,000
60,740 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
0.24%
|
$721,000
49,441 shares
|
— | 30 Jun 2020 |
| MYDA Advisors LLC |
13F
Company
|
0.19%
|
$583,000
40,000 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
6,803,921
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
22
Q3 2020 holders
45
Holder diff
23
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend